{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:42:06Z","timestamp":1780393326201,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2012.09.060","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:17:54Z","timestamp":1386634674000},"page":"J73-J78","source":"Crossref","is-referenced-by-count":12,"special_numbering":"S9","title":["Key outcomes and addressing remaining challenges\u2014Perspectives from a final evaluation of the China GAVI project"],"prefix":"10.1016","volume":"31","author":[{"given":"Weizhong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Hadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan J.","family":"Hutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.09.060_bib0155","doi-asserted-by":"crossref","first-page":"J8","DOI":"10.1016\/j.vaccine.2012.12.019","article-title":"Origins, design and implementation of the China GAVI project","volume":"31","author":"Liang","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2012.09.060_bib0010","series-title":"Tool for the assessment of injection safety. WHO\/V&B\/01.30","author":"WHO","year":"2001"},{"key":"10.1016\/j.vaccine.2012.09.060_bib0160","doi-asserted-by":"crossref","first-page":"J29","DOI":"10.1016\/j.vaccine.2012.07.048","article-title":"Preventing hepatitis B though universal vaccination: reduction of inequities through the China GAVI Project","volume":"31","author":"Cui","year":"2013","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2012.09.060_bib0165","doi-asserted-by":"crossref","first-page":"J43","DOI":"10.1016\/j.vaccine.2012.11.057","article-title":"Evaluation of immunization injection safety in China, 2010: achievements, future sustainability","volume":"31","author":"Wu","year":"2013","journal-title":"Vaccine."},{"issue":"47","key":"10.1016\/j.vaccine.2012.09.060_bib0025","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China\u2014declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.09.060_bib0030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0928-4346(96)82012-3","article-title":"Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemologic study of hepatitis A, B, C, D, and E virus infections in China, 1992","volume":"5","author":"Xia","year":"1996","journal-title":"Int Hepatol Commun"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2012.09.060_bib0035","first-page":"19","article-title":"An epidemiological study on the distribution of HBsAg and anti-HBs in China","author":"Qu","year":"1986","journal-title":"Chin J Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2012.09.060_bib0040","first-page":"405","article-title":"Hepatitis B vaccine, WHO position paper","volume":"84","author":"WHO","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"issue":"19","key":"10.1016\/j.vaccine.2012.09.060_bib0045","first-page":"180","article-title":"Progress towards meeting the 2012 hepatitis B control milestone: WHO Western Pacific Region, 2011","volume":"86","author":"WPRO","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"10.1016\/j.vaccine.2012.09.060_bib0050","first-page":"481","article-title":"Study on the surveillance of adverse events following immunization in China: 2007\u20132008","volume":"15","author":"Wu","year":"2009","journal-title":"Chin J Vacc Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2012.09.060_bib0055","first-page":"505","article-title":"Study on the surveillance of adverse events following immunization in China: 2005\u20132006","volume":"13","author":"Liu","year":"2007","journal-title":"Chin J Vacc Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.060_bib0060","first-page":"52","article-title":"Analysis on the adverse events following immunization of 10 infants death after hepatitis B vacciantion","volume":"15","author":"Wang","year":"2009","journal-title":"Chin J Vacc Immun"},{"key":"10.1016\/j.vaccine.2012.09.060_bib0065","series-title":"Building trust and responding to adverse events following immunization in south Asia","author":"UNICEF","year":"2005"},{"issue":"3","key":"10.1016\/j.vaccine.2012.09.060_bib0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.vaccine.2009.10.110","article-title":"Hepatitis B vaccines: WHO position paper\u2014recommendations","volume":"28","author":"WHO","year":"2010","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2012.09.060_bib0075","first-page":"180","article-title":"Progress towards meeting the 2012 hepatitis B control milestone: WHO Western Pacific Region, 2011","volume":"86","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2012.09.060_bib0080","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004790.pub2","article-title":"Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers","volume":"2","author":"Lee","year":"2006","journal-title":"Cochrane Database Syst Rev (Online)"},{"issue":"18","key":"10.1016\/j.vaccine.2012.09.060_bib0085","first-page":"441","article-title":"Progress in hepatitis B prevention through universal infant immunization\u2014China: 1997\u20132006","volume":"56","author":"Cui","year":"2007","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2012.09.060_bib0090","series-title":"The sixtieth world health assembly","article-title":"Worker's health:global plan of action","author":"WHO","year":"2007"},{"key":"10.1016\/j.vaccine.2012.09.060_bib0095","series-title":"Sixty-third world health assembly","article-title":"Viral hepatitis, A63\/15","author":"WHO","year":"2010"},{"key":"10.1016\/j.vaccine.2012.09.060_bib0100","series-title":"The analysis on Chinese new health reforming system and it'ssustainability","author":"Ding","year":"2008"},{"issue":"5","key":"10.1016\/j.vaccine.2012.09.060_bib0105","first-page":"334","article-title":"Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai: China","volume":"81","author":"Ding","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.vaccine.2012.09.060_bib0110","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4269\/ajtmh.2010.09-0748","article-title":"Japanese encephalitis disease burden and clinical features of Japanese encephalitis in four cities in the People's Republic of China","volume":"83","author":"Yin","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2012.09.060_bib0115","first-page":"474","article-title":"Study on the cost-effectiveness: benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai","volume":"25","author":"Wu","year":"2004","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"6","key":"10.1016\/j.vaccine.2012.09.060_bib0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ajim.20230","article-title":"Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers","volume":"48","author":"Pruss-Ustun","year":"2005","journal-title":"Am J Ind Med"},{"issue":"4","key":"10.1016\/j.vaccine.2012.09.060_bib0125","first-page":"289","article-title":"Evaluation on impact of hepatitis B vaccine integrated into routine immunization in Ministry of Health\/Global Alliance for Vaccine and Immunization GAVI cooperation project areas, P.R. China","volume":"15","author":"Cui","year":"2009","journal-title":"Chin J Vacc Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2012.09.060_bib0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hep.23310","article-title":"Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China","volume":"51","author":"Hutton","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.vaccine.2012.09.060_bib0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajic.2003.03.003","article-title":"Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt","volume":"31","author":"Talaat","year":"2003","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.060_bib0140","first-page":"13","article-title":"Vaccination for the hepatitis B virus in primary care health staff: prevalence, affecting factors and need","volume":"22","author":"Mayo Ferreiro","year":"1998","journal-title":"Aten Primaria"},{"issue":"4","key":"10.1016\/j.vaccine.2012.09.060_bib0145","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/00365520701733806","article-title":"A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting","volume":"43","author":"Sangfelt","year":"2008","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.vaccine.2012.09.060_bib0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/646078","article-title":"Hepatitis B immunoprophylaxis: developing a cost-effective program in the hospital setting","volume":"11","author":"Lanphear","year":"1990","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12013801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T04:27:17Z","timestamp":1538972837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12013801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":30,"alternative-id":["S0264410X12013801"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.060","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}